Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.

Misonidazole has been demonstrated to enhance the cytotoxicity of several common antineoplastic drugs in vitro and in vivo, and its mechanism of action as a chemosensitizer, though still unknown, is thought to be dependent upon hypoxia. We have used fluorescence-activated cell sorting to evaluate ch...

Full description

Bibliographic Details
Main Authors: Durand, R. E., Chaplin, D. J.
Format: Online
Language:English
Published: 1987
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002149/
id pubmed-2002149
recordtype oai_dc
spelling pubmed-20021492009-09-10 Chemosensitization by misonidazole in CCNU-treated spheroids and tumours. Durand, R. E. Chaplin, D. J. Research Article Misonidazole has been demonstrated to enhance the cytotoxicity of several common antineoplastic drugs in vitro and in vivo, and its mechanism of action as a chemosensitizer, though still unknown, is thought to be dependent upon hypoxia. We have used fluorescence-activated cell sorting to evaluate chemopotentiation by misonidazole as a function of cell position in V79 spheroids and KHT tumours. CCNU toxicity was enhanced in all cell subpopulations of both tumours and spheroids, with greater consistency than might be predicted on the basis of the known variations in oxygen tension. Further, both misonidazole and CCNU as single agents were preferentially toxic in the less well oxygenated regions of each system, arguing that differential toxicity cannot be implicated in the chemopotentiation observed. In fact, increased treatment toxicity did not necessarily lead to increased chemopotentiation, nor was potentiation directly related to the metabolism/binding of the misonidazole. Chemopotentiation in multicell systems thus appears to be a complex, multi-factorial process. 1987-08 /pmc/articles/PMC2002149/ /pubmed/3663461 Text en
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Durand, R. E.
Chaplin, D. J.
spellingShingle Durand, R. E.
Chaplin, D. J.
Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
author_facet Durand, R. E.
Chaplin, D. J.
author_sort Durand, R. E.
title Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
title_short Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
title_full Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
title_fullStr Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
title_full_unstemmed Chemosensitization by misonidazole in CCNU-treated spheroids and tumours.
title_sort chemosensitization by misonidazole in ccnu-treated spheroids and tumours.
description Misonidazole has been demonstrated to enhance the cytotoxicity of several common antineoplastic drugs in vitro and in vivo, and its mechanism of action as a chemosensitizer, though still unknown, is thought to be dependent upon hypoxia. We have used fluorescence-activated cell sorting to evaluate chemopotentiation by misonidazole as a function of cell position in V79 spheroids and KHT tumours. CCNU toxicity was enhanced in all cell subpopulations of both tumours and spheroids, with greater consistency than might be predicted on the basis of the known variations in oxygen tension. Further, both misonidazole and CCNU as single agents were preferentially toxic in the less well oxygenated regions of each system, arguing that differential toxicity cannot be implicated in the chemopotentiation observed. In fact, increased treatment toxicity did not necessarily lead to increased chemopotentiation, nor was potentiation directly related to the metabolism/binding of the misonidazole. Chemopotentiation in multicell systems thus appears to be a complex, multi-factorial process.
publishDate 1987
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2002149/
_version_ 1611402042451951616